DDB2 can inhibit the ovarian cancer cell dedifferentiation through downregulation of ALDH1A1; a selective ALDH1A1 inhibitor is able to reduce the tumorigenic CSC subpopulation and halt tumor growth in ovarian cancer cells possessing low levels of DDB2. The gene discussed is ALDH1A1; the disease is ovarian carcinoma.